Benefit of Ambulatory Management of Patients with Chronic Heart Failure by Protocolized Follow-Up Therapeutic Education and Remote Monitoring Solution: An Original Study in 159 Patients.

care pathway coordination unit heart failure personalized medicine protocolized follow-up remote monitoring solution telemedicine therapeutic education

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
25 Sep 2020
Historique:
received: 08 09 2020
revised: 18 09 2020
accepted: 24 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

This study sought to determine whether the implementation of regular and structured follow-up of patients with chronic heart failure (CHF), combined with therapeutic education and remote monitoring solution, leads to better management. This was a single-center retrospective study conducted in a cohort of patients with proven CHF who were followed up in the Mulhouse region (France) between January 2016 and December 2017 by the Unité de Suivi des Patients Insuffisants Cardiaques (USICAR) unit. These patients received regular protocolized follow-up, a therapeutic education program, and several used a telemedicine platform for a two-year period. The primary endpoint was the number of days hospitalized for heart failure (HF) per patient per year. The main secondary endpoints included the number of days hospitalized for a heart condition other than HF and the number of hospital stays for HF per patient. These endpoints were collected during the year preceding enrollment, at one year of follow-up, and at two years of follow-up. The remote monitoring solution was evaluated on the same criterion. Overall, 159 patients with a mean age of 72.9 years were included in this study. They all had CHF, mainly NYHA Class I-II (88.7%), predominantly of ischemic origin (50.9%), and with altered left ventricular ejection fraction in 69.2% of cases. The mean number of days hospitalized for HF per patient per year was 8.33 (6.84-10.13) in the year preceding enrollment, 2.6 (1.51-4.47) at one year of follow-up, and 2.82 at two years of follow-up (1.30-6.11) (

Identifiants

pubmed: 32993030
pii: jcm9103106
doi: 10.3390/jcm9103106
pmc: PMC7599658
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fondation de la Maison du Diaconat de Mulhouse
ID : 50000

Références

J Clin Med. 2018 Dec 13;7(12):
pubmed: 30551588
Lancet. 2018 Sep 22;392(10152):1047-1057
pubmed: 30153985
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur J Heart Fail. 2019 Oct;21(10):1169-1186
pubmed: 31129923
Arch Cardiovasc Dis. 2013 Nov;106(11):570-85
pubmed: 24140417
Am Heart J. 2007 Aug;154(2):260-6
pubmed: 17643574
Eur J Heart Fail. 2005 Mar 16;7(3):363-9
pubmed: 15718176
Int J Cardiol. 2013 Oct 9;168(4):3652-8
pubmed: 23809709
Rev Med Interne. 2005 Nov;26(11):845-50
pubmed: 15935520
ESC Heart Fail. 2018 Dec;5(6):989-1007
pubmed: 30570225
Am J Med. 2003 Jun 1;114(8):625-30
pubmed: 12798449

Auteurs

Anne Jenneve (A)

Unité de Suivi des Patients Insuffisants Cardiaques, Clinique du Diaconat, 68067 Mulhouse, France.

Noel Lorenzo-Villalba (N)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Equipe de Recherche EA 3072-Mitochondrie, Stress Oxydant et Protection Musculaire, Faculté de Médecine de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France.

Guy Courdier (G)

Unité de Suivi des Patients Insuffisants Cardiaques, Clinique du Diaconat, 68067 Mulhouse, France.

Samy Talha (S)

Equipe de Recherche EA 3072-Mitochondrie, Stress Oxydant et Protection Musculaire, Faculté de Médecine de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France.
Service de Physiologie et d'Explorations Fonctionnelles, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

François Séverac (F)

Département de Santé Publique/DIM et Biostatistiques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Abrar-Ahmad Zulfiqar (AA)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Equipe de Recherche EA 3072-Mitochondrie, Stress Oxydant et Protection Musculaire, Faculté de Médecine de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France.

Patrick Arnold (P)

Unité de Suivi des Patients Insuffisants Cardiaques, Clinique du Diaconat, 68067 Mulhouse, France.

Philippe Lang (P)

Unité de Suivi des Patients Insuffisants Cardiaques, Clinique du Diaconat, 68067 Mulhouse, France.

Gérald Roul (G)

Unité Fonctionnelle Dédiée à L'insuffisance Cardiaque, Pôle Médical et Chirurgical des Maladies Cardio-vasculaires, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Emmanuel Andrès (E)

Service de Médecine Interne, Diabète et Maladies Métaboliques, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Equipe de Recherche EA 3072-Mitochondrie, Stress Oxydant et Protection Musculaire, Faculté de Médecine de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France.

Classifications MeSH